The favorable market reaction indicates investor relief at management’s swift measures to rectify the company's worsening ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced a ...

For Sarepta, the hits keep coming, with several downgrades in the past week after it was forced to temporarily take its ...

The company agreed to voluntarily halt shipments of its experimental medicine Elevidys for Duchenne muscular dystrophy.

Sarepta stock plunged again Thursday on a report the FDA will require additional clinical testing to validate the safety ...

On this news, the price of Sarepta stock fell more than 8%. Investors who purchased or otherwise acquired shares of Sarepta should contact the Firm prior to the August 25, 2025 lead plaintiff ...

The Sarepta class action lawsuit alleges that on this news, the price of Sarepta stock fell more than 42%.

SRPT INVESTOR NOTICE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit ...

Atlassian shares plunged 9% Thursday as a regulatory filing showed the company’s CEO sold over $1.6 million of company stock earlier in the week.

The Mass. 100 index of largest publicly traded companies in Massachusetts gets a refresh. See which firms rose, fell and debuted on the list for 2025.

Nike shares jumped 15% Friday, a day after the athletic apparel giant topped fiscal fourth-quarter estimates.

Mega-Cap Movers (Market Cap $200B+): Large-Cap Stock Movers (Market Cap $10B-$200B): New Providence Acquisition Corp N (ASTS): +8.77% CoreWeave (CRWV): CoreWeave stock initiated with Reduce rating by ...